You are leaving Smmttx.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible
for its contents.

Summit Therapeutics, Inc., is not responsible for the privacy notice of any third-party websites. We encourage you to read the privacy notice of every website you visit.

To stay on Summit’s website, click “Cancel” or click “Continue” to proceed.

Patients & Caregivers

Developing Innovative Medications for Patients in Need

For Patients & Caregivers

At Summit Therapeutics, the unmet healthcare needs of patients is what motivates us to bring the medical solutions needed to make a difference to people’s lives. This page will provide extra information to help you on your healthcare journey.

What is a Clinical Trial?

Clinical trials are research studies in which people volunteer to participate. They are designed to answer specific questions about the safety or effectiveness of drugs, other therapies, or new ways of using existing treatments. Thousands of volunteers all around the world participate in clinical trials every year; they decide to do it for many different reasons. The efforts of many people, and especially those that volunteer to participate in clinical trials, help make medical advances happen.

If you or someone you love is on osimertinib for advanced lung cancer:

There is a phase 3 clinical trial called HARMONi for patients with lung cancer who have an EGFR mutation and have progressed on osimertinib.

Click to Learn More

If you or someone you love is on osimertinib for advanced lung cancer:

There is a phase 3 clinical trial called HARMONi for patients with lung cancer who have an EGFR mutation and have progressed on osimertinib.

Click to Learn More

Running clinical trials that can support regulatory approvals is the best way to ultimately ensure wide access for patients to our drug candidates. Therefore, all of our efforts remain focused on conducting rigorous clinical trials to establish the safety and potential clinical benefits that these candidates may have. At this point in the development, we cannot support any use of our drug candidates outside of clinical trials.

 

For additional information please visit the following patient advocacy groups: